Aspira Women's Health(us:AWH)

0.0958

-8.94%

Updated on 2025-03-31

Open:0.0999
Close:0.0958
High:0.1000
Low:0.0900
Prev Close:0.1052
Volume:1.25M
Turnover:124371.27
Turnover Ratio:4.21%
Shares:29.76M
MarketCap:2.85M
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-3028139585410.88%596
2024-03-3126189251415.33%2107
2023-12-31297153246.72%5108
2023-09-30266578366.39%499
2023-06-30476747947.96%2636
2023-03-31535917950.47%61316
2022-12-316197251777.81%5630
2022-09-30781266537910.18%91136
dateorgNametotalratiochangeShareschangeRatio
2024-03-31Armistice Capital, Llc11570009.37%1157000
2024-03-31Vanguard Group Inc2774072.25%8140041.53%
2024-03-31B. Riley Wealth Advisors, Inc.1253741.02%-53997-30.10%
2024-03-31Blackrock Inc.627660.51%0
2024-03-31Geode Capital Management, Llc595440.48%22153.86%
2024-03-31Quantum Private Wealth, Llc524180.42%22624.51%
2024-03-31Northern Trust Corp333350.27%-2714-7.53%
2024-03-31Bank Of America Corp /De/293540.24%1710.59%
2024-03-31Squarepoint Ops Llc254380.21%1007365.56%
2024-03-31Northeast Financial Consultants Inc234360.19%0

About

Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.
Address:12117 Bee Caves Road,Suite 100,Building III

Market Movers